Q1 2023 Holdings
Filed 2023-05-15 | 48 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech Ltd.(SVA) | SHS | P8696W104 | $615.4M | 5,900,000 | 42.7% |
| Genetron Holdings Ltd | ADS | 37186H100 | $104.6M | 8,124,174 | 7.3% |
| Verona Pharma PLC(VRNA) | ADS | 925050106 | $85.3M | 4,249,918 | 5.9% |
| Harmony Biosciences Holdings Inc(HRMY) | Common | 413197104 | $85.1M | 2,606,247 | 5.9% |
| Terns Pharmaceuticals Inc(TERN) | Common | 880881107 | $78.8M | 6,657,992 | 5.5% |
| Viridian Therapeutics Inc(VRDN) | Common | 92790C104 | $42.7M | 1,678,207 | 3.0% |
| Geron Corp(GERN) | Common | 374163103 | $41.8M | 19,282,834 | 2.9% |
| Avadel Pharmaceuticals PLC | ADR | 05337M104 | $34.5M | 3,761,438 | 2.4% |
| Tarsus Pharmaceuticals Inc(TARS) | Common | 87650L103 | $28.4M | 2,262,200 | 2.0% |
| Astria Therapeutics Inc(CATBUSD) | Common | 04635X102 | $22.4M | 1,681,199 | 1.6% |
| Vaxcyte Inc(PCVX) | Common | 92243G108 | $21.7M | 579,508 | 1.5% |
| Cogent Biosciences Inc(COGT) | Common | 19240Q201 | $21.5M | 1,994,941 | 1.5% |
| Chinook Therapeutics Inc(290A) | Common | 16961L106 | $20.2M | 872,151 | 1.4% |
| Ventyx Biosciences Inc(VTYX) | Common | 92332V107 | $20.2M | 602,075 | 1.4% |
| VectivBio Holding AG | Common | H9060V101 | $19.9M | 2,333,300 | 1.4% |
| ALX Oncology Holdings Inc(ALXO) | Common | 00166B105 | $19.1M | 4,220,048 | 1.3% |
| Allakos Inc(ALLKGUSD) | Common | 01671P100 | $18.3M | 4,120,134 | 1.3% |
| Zai Lab Ltd ADR(ZLAB) | ADR | 98887Q104 | $13.9M | 416,640 | 1.0% |
| Legend Biotech Corp Sponsored(LEGN) | SPONSORED ADS | 52490G102 | $11.8M | 244,375 | 0.8% |
| Compass Therapeutics Inc(CMPX) | Common | 20454B104 | $11.6M | 3,556,023 | 0.8% |
| Amyris, Inc(AMRSEUR) | Common | 03236M200 | $10.5M | 7,750,828 | 0.7% |
| Arcellx Inc.(ACLX) | Common | 03940C100 | $9.0M | 290,713 | 0.6% |
| Instil Bio Inc | Common | 45783C101 | $8.3M | 12,486,787 | 0.6% |
| Bellus Health Inc(BLU) | Common | 07987C204 | $7.3M | 1,017,152 | 0.5% |
| Aclaris Therapeutics, Inc.(ACRS) | Common | 00461U105 | $7.3M | 898,631 | 0.5% |
| Sera Prognostics Inc(SERA) | Common | 81749D107 | $7.1M | 1,856,011 | 0.5% |
| KalVista Pharmaceuticals Inc.(KALV) | Common | 483497103 | $6.7M | 856,008 | 0.5% |
| Dyne Therapeutics Inc(DYN) | Common | 26818M108 | $6.7M | 577,642 | 0.5% |
| Merus NV | Common | N5749R100 | $6.5M | 353,600 | 0.5% |
| Aadi Bioscience Inc(WHWK) | Common | 00032Q104 | $6.5M | 509,572 | 0.4% |
| Olema Pharmaceuticals Inc(OLMA) | Common | 68062P106 | $5.9M | 1,689,515 | 0.4% |
| IO Biotech Inc(IOBT) | Common | 449778109 | $5.7M | 3,015,545 | 0.4% |
| Bolt Therapeutics Inc(BOLT1EUR) | Common | 097702104 | $5.4M | 3,871,291 | 0.4% |
| DBV Technologies SA | Sponsored ADR | 23306J101 | $4.6M | 2,708,875 | 0.3% |
| Impel NeuroPharma Inc | Common | 45258K109 | $4.0M | 2,884,789 | 0.3% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $4.0M | 655,057 | 0.3% |
| Arrowhead Pharmaceuticals Inc(ARWR) | Common | 04280A100 | $3.5M | 137,411 | 0.2% |
| Aligos Therapeutics Inc | Common | 01626L105 | $3.1M | 3,547,030 | 0.2% |
| Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | $2.7M | 1,463,983 | 0.2% |
| BioAtla Inc(BCAB) | Common | 09077B104 | $1.7M | 637,181 | 0.1% |
| Aslan Pharmaceuticals Ltd | ADS | 04522R101 | $1.6M | 2,840,909 | 0.1% |
| Codexis, Inc(CDXS) | Common | 192005106 | $1.6M | 388,144 | 0.1% |
| Fulcrum Therapeutics Inc(FULC) | Common | 359616109 | $1.6M | 550,000 | 0.1% |
| Immunic Inc(IMUX) | Common | 4525EP101 | $942.0K | 632,184 | 0.1% |
| Rezolute Inc(RZLT) | Common | 76200L309 | $939.8K | 489,473 | 0.1% |
| Minerva Surgical Inc | Common | 60343F106 | $486.3K | 2,215,667 | 0.0% |
| Homology Medicines, Inc. | Common | 438083107 | $381.2K | 370,068 | 0.0% |
| Precision Biosciences Inc | Common | 74019P108 | $105.7K | 140,255 | 0.0% |